As U.S. Drug Company Draws Scrutiny, Connecticut Activists Seek To Raise Awareness About HIV/AIDS | Connecticut Public Radio
WNPR

As U.S. Drug Company Draws Scrutiny, Connecticut Activists Seek To Raise Awareness About HIV/AIDS

May 20, 2019

Gilead, the biopharmaceutical company responsible for manufacturing Truvada, has come under scrutiny for its HIV drug pricing. This hour, we get the latest on this story. We also preview an upcoming Hartford rally, scheduled to coincide with AIDS Awareness Day. 

Plus, for various reasons, a couple might decide to have their embryos frozen. But what happens to those embryos after the couple divorces? We learn about a state Supreme Court case, which centers on this very issue.

And finally, the SAT has a new score. An adversity score, to be more specific. We find out what this means and check in on Connecticut’s SAT requirements.

Join the conversation on Facebook and Twitter.

GUESTS:

Chion Wolf contributed to this show.